Skip to main content

NIH grant expands capacity to train emerging cancer researchers in Malawi

September 28, 2021

  A five-year training grant from the National Institutes of Health’s National Cancer Institute expands the capacity of UNC’s Institute for Global Health & Infectious Diseases and Lineberger Comprehensive Cancer Center to train the next generation of cancer researchers in Malawi, Africa. The Malawi Cancer Outcomes Research Program, or M-CORP, includes funding for advanced degree … Continued

Hobbs and Duncan win $3.9M NIAID grant to study a meningitis vaccine’s effect on gonorrhea

August 26, 2021

The NIH’s National Institute of Allergy and Infectious Diseases has awarded UNC’s Marcia Hobbs and Alex Duncan a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with Neisseria gonorrhoeae, a sexually transmitted bacterial … Continued

NIH awards HIV Cure Center $26.2 million over next 5 years

August 23, 2021

The National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research program, initiated in 2011, further expand the initiative’s 2016 renewal from six institutions to … Continued

Boyce awarded Doris Duke funding for malaria study in Uganda

August 17, 2021

The Doris Duke Charitable Foundation has awarded Ross Boyce, MD, MSc, a 2021 Clinical Scientist Development Award for his research proposal entitled, “Getting malaria off the back of women and children in western Uganda,” which aims at reducing the incidence of malaria among infants and young children in rural Uganda. Boyce, an assistant professor in … Continued

Bamlanivimab reduces risk of COVID in skilled nursing homes and assisted living facilities, study finds

July 21, 2021

UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The randomized phase 3 clinical trial … Continued

Study compares mortality of people entering HIV care with general US population

July 21, 2021

HIV-related mortality has decreased since 1996 due to improved treatments and evolving care guidelines, but the extent to which persons entering HIV care have a higher risk for death over the following years, compared with peers in the general population, has been unclear. Joseph Eron, MD, the Herman and Louise Smith Distinguished Professor of Medicine … Continued

Immunocompromised Host ID Fellows land faculty positions

May 9, 2021

The first two graduates of UNC’s Immunocompromised Host Infectious Disease Fellowship program have successfully landed faculty positions. Tyler Lambing, MD, the 2019-2020 fellow, has joined Baylor College of Medicine as an assistant professor. Daphne-Dominique Henson Villanueva, MD, the 2020-2021fellow, begins her post as an assistant professor at the West Virginia University in July 2021. The … Continued

Baric elected to National Academy of Sciences

May 9, 2021

Ralph S Baric, UNC’s William R. Kenan Jr. Distinguished Professor of Epidemiology and professor of microbiology and immunology, was one of four UNC-Chapel Hill faculty members elected as part of a class of 120 new members to the National Academy of Sciences. The honor recognizes a member’s distinguished and continuing achievements in original research. Baric … Continued

Report from Malawi: Weathering a second wave—or tsunami—of COVID-19

February 10, 2021

  By Mina Hosseinipour, MD, MPH Officials announced the first confirmed case of COVID-19 in Malawi on April 2, 2020. At UNC Project Malawi, we’d been working for a month to carefully review and prepare for the virus. We established COVID preventive procedures and clinical management guidelines and planning for staff and staff relatives. We … Continued

Office of Global Health Education funds COVID-19 research, service learning projects

February 2, 2021

Projects include vaccinating farmworkers arriving in North Carolina, managing data from Nicaragua, and testing blood samples from Africa   UNC’s Office of Global Health Education (OGHE) is awarding $23,000 to teams of global health faculty and medical students to pursue COVID-19 related research and service learning in the spring or summer of 2021. During a … Continued

UNC investigators help prove a monoclonal antibody prevents, treats COVID-19 in nursing homes

January 21, 2021

  Eli Lilly today released results of a clinical trial that found bamlanivimab, a monoclonal antibody, significantly reduced the risk of contracting COVID-19 among residents and staff of long-term care facilities. The Phase 3 trial was conducted in partnership with the NIH’s National Institute of Allergy and Infectious Diseases and the COVID-19 Prevention Network (CoVPN). … Continued

‘Why I’m still alive’: A patient’s gratitude, two decades later

January 13, 2021

In the summer of 2001, Shani Morgan was a few months pregnant and in prison, where she learned that she had HIV. She’d been sent from jail to Bragg Street Women’s Prison in Raleigh for better monitoring and medical treatment. What she remembers most about being treated by her UNC doctor, Becky White, MD, MPH, … Continued

UNC’s infectious diseases program ranked 11th globally

January 4, 2021

U.S. News & World Report has ranked the University of North Carolina-Chapel Hill 11th among universities globally for its infectious diseases program. The Best Global Universities rankings, now in their seventh year, focus on academic research, publications and citations, international collaboration, and overall reputation. This is the first time infectious diseases programs have been included … Continued

A Safe Space

December 17, 2020

A collaborative team, drawing in part on experience working with disease outbreaks in Africa, has remarkably transformed UNC’s Medical Intensive Care Unit to treat COVID-19 patients. They’ve demonstrated that it’s possible to provide critical care for patients while keeping providers safe. Like most of us during the pandemic, Billy Fischer, MD, has stayed put the … Continued

Gates Foundation awards UNC Global Women’s Health $6.2 million to study pregnancy outcomes in Zambia

December 9, 2020

UNC Global Women’s Health has received two new grants from the Bill and Melinda Gates Foundation for work on pregnancy outcomes in Zambia. The first grant funds the “Multi-omics for Mother and Infants (MOMI) Consortium,” which seeks to identify new predictive biomarkers for preterm birth, preeclampsia, stillbirth and fetal growth restriction. UNC Project-Zambia is one … Continued

Three Institute faculty elected IDSA Fellows

December 7, 2020

The Infectious Diseases Society of America, the nation’s leading infectious diseases professional society, has elected the Institute’s Joseph Eron, MD; Anne Lachiewicz, MD, MPH; and Christopher Hurt, MD, to its latest cohort of Fellows of IDSA. As the highest honor in the field of infectious diseases, IDSA fellowships recognize those who have achieved professional excellence … Continued

NIH awards $25 million to UNC’s Global HIV Clinical Trials Unit

November 30, 2020

  The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant women at four research sites … Continued